The Europe Antimicrobial Resistance Diagnostics Market would witness market growth of 5.4% CAGR during the forecast period (2022-2028).
Antibiotics, a bacteria-specific antimicrobial, are said to be one of the most significant therapeutic advancements in medical history. They have transformed how physicians care for people who have bacterial infections and also have helped to lower the morbidity and mortality associated with infectious diseases. They are also a crucial component of modern medicine, and without the provision of strong antibiotics, common treatments like transplantation, cancer chemotherapy, and even orthopedic surgery would not be possible.
These drugs, however, have a history of abuse. They are frequently taken for viral infections even though they don't work against them. Similar to inaccurate diagnoses, when the causal microorganism is unknown, broad-spectrum antibiotics, antibiotics that kill a lot of different bacteria rather than just the germs that cause the disease, are frequently recommended.
The pharmaceutical, veterinary, and agricultural sectors, as well as individuals at any stage of life, could be impacted by antimicrobial resistance. This makes the issue one of the most important public health issues on the entire planet. To be hazardous, fungi and bacteria do not necessarily need to be immune to all antibiotics or antifungals. Even a single drug resistance can lead to major issues. Infections that are resistant to first- and second-line antibiotics can affect the patient by resulting in serious side effects like organ failure and delaying treatment and recovery for weeks or even months.
The general decreases in antibiotic use seen in the European region over the past few years imply that concerted, region-wide efforts to promote the wise usage of antibiotics have been successful. Yet in 2020, the average community intake of broad-spectrum antibiotics medicines was 3.5 times higher than that of narrow-spectrum medicines, which are often the first line of treatment. Presently a wide range of AMR in bacteria from infections in humans across EU nations, such as E. faecalis' resistance to vancomycin or K. pneumoniae's and P. aeruginosa's and Acinetobacter species' resistance to carbapenems can be found. These provide significant opportunities to reduce AMR through measures that enhance infection control and prevention in addition to antimicrobial preservation practices. Hence, the usage of AMR diagnostics has increased, which has propelled the expansion of the antimicrobial resistance diagnostics market in the coming years.
The Germany market dominated the Europe Antimicrobial Resistance Diagnostics Market by Country in 2021; thereby, achieving a market value of $369.1 million by 2028. The UK market is exhibiting a CAGR of 4.6% during (2022 - 2028). Additionally, The France market would experience a CAGR of 6.2% during (2022 - 2028).
Based on Technology, the market is segmented into PCR, Immunoassay, NGS, Microbiology Culture, Mass Spectrometry, Rapid & Point of Care and Others. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Pharmaceutical, Biotechnology Companies & Others. Based on Pathogen, the market is segmented into Methicillin Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile (CD), Drug Resistant Campylobacter (DRC), Drug Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRNTS) and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Antimicrobial Resistance Diagnostics Market will Hit $5.7 Billion by 2028, at a CAGR of 6.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Danaher Corporation, Accelerate Diagnostics, Inc., Hologic, Inc., Visby Medical, Inc., Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd) and Molsid S.A.S.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- PCR
- Immunoassay
- NGS
- Microbiology Culture
- Mass Spectrometry
- Rapid & Point of Care
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical, Biotechnology Companies & Others
By Pathogen
- Methicillin Resistant Staphylococcus Aureus (MRSA)
- Clostridium Difficile (CD)
- Drug Resistant Campylobacter (DRC)
- Drug Resistant Streptococcus Pneumoniae (DRSP)
- Drug Resistant Neisseria Gonorrhoeae (DRNG)
- Drug Resistant Salmonella (DRNTS)
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- BioMérieux S.A.
- F.Hoffmann-La Roche Ltd.
- Becton, Dickinson and Company
- Danaher Corporation
- Accelerate Diagnostics, Inc.
- Hologic, Inc.
- Visby Medical, Inc.
- Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd)
- Molsid S.A.S.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Antimicrobial Resistance Diagnostics Market, by Technology
1.4.2 Europe Antimicrobial Resistance Diagnostics Market, by End User
1.4.3 Europe Antimicrobial Resistance Diagnostics Market, by Pathogen
1.4.4 Europe Antimicrobial Resistance Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Europe Antimicrobial Resistance Diagnostics Market by Technology
4.1 Europe PCR Market by Country
4.2 Europe Immunoassay Market by Country
4.3 Europe NGS Market by Country
4.4 Europe Microbiology Culture Market by Country
4.5 Europe Mass Spectrometry Market by Country
4.6 Europe Rapid & Point of Care Market by Country
4.7 Europe Others Market by Country
Chapter 5. Europe Antimicrobial Resistance Diagnostics Market by End-user
5.1 Europe Hospitals Market by Country
5.2 Europe Diagnostic Laboratories Market by Country
5.3 Europe Pharmaceutical, Biotechnology Companies & Others Market by Country
Chapter 6. Europe Antimicrobial Resistance Diagnostics Market by Pathogen
6.1 Europe Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
6.2 Europe Clostridium Difficile (CD) Market by Country
6.3 Europe Drug Resistant Campylobacter (DRC) Market by Country
6.4 Europe Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
6.5 Europe Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
6.6 Europe Drug Resistant Salmonella (DRNTS) Market by Country
6.7 Europe Others Market by Country
Chapter 7. Europe Antimicrobial Resistance Diagnostics Market by Country
7.1 Germany Antimicrobial Resistance Diagnostics Market
7.1.1 Germany Antimicrobial Resistance Diagnostics Market by Technology
7.1.2 Germany Antimicrobial Resistance Diagnostics Market by End-user
7.1.3 Germany Antimicrobial Resistance Diagnostics Market by Pathogen
7.2 UK Antimicrobial Resistance Diagnostics Market
7.2.1 UK Antimicrobial Resistance Diagnostics Market by Technology
7.2.2 UK Antimicrobial Resistance Diagnostics Market by End-user
7.2.3 UK Antimicrobial Resistance Diagnostics Market by Pathogen
7.3 France Antimicrobial Resistance Diagnostics Market
7.3.1 France Antimicrobial Resistance Diagnostics Market by Technology
7.3.2 France Antimicrobial Resistance Diagnostics Market by End-user
7.3.3 France Antimicrobial Resistance Diagnostics Market by Pathogen
7.4 Russia Antimicrobial Resistance Diagnostics Market
7.4.1 Russia Antimicrobial Resistance Diagnostics Market by Technology
7.4.2 Russia Antimicrobial Resistance Diagnostics Market by End-user
7.4.3 Russia Antimicrobial Resistance Diagnostics Market by Pathogen
7.5 Spain Antimicrobial Resistance Diagnostics Market
7.5.1 Spain Antimicrobial Resistance Diagnostics Market by Technology
7.5.2 Spain Antimicrobial Resistance Diagnostics Market by End-user
7.5.3 Spain Antimicrobial Resistance Diagnostics Market by Pathogen
7.6 Italy Antimicrobial Resistance Diagnostics Market
7.6.1 Italy Antimicrobial Resistance Diagnostics Market by Technology
7.6.2 Italy Antimicrobial Resistance Diagnostics Market by End-user
7.6.3 Italy Antimicrobial Resistance Diagnostics Market by Pathogen
7.7 Rest of Europe Antimicrobial Resistance Diagnostics Market
7.7.1 Rest of Europe Antimicrobial Resistance Diagnostics Market by Technology
7.7.2 Rest of Europe Antimicrobial Resistance Diagnostics Market by End-user
7.7.3 Rest of Europe Antimicrobial Resistance Diagnostics Market by Pathogen
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 BioMérieux S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition, Joint Ventures and Mergers:
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Danaher Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 Hologic, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Financial Analysis
8.6.4 Segmental and Regional Analysis
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Acquisition and Mergers:
8.7 Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Molsid SAS
8.8.1 Company Overview
8.9 Visby Medical, Inc.
8.9.1 Company Overview
8.10. Accelerated Technology Laboratories, Inc.
8.10.1 Company Overview
TABLE 1 Europe Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 Europe Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Antimicrobial Resistance Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Antimicrobial Resistance Diagnostics Market
TABLE 5 Acquisition and Mergers– Antimicrobial Resistance Diagnostics Market
TABLE 6 Europe Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 7 Europe Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 8 Europe PCR Market by Country, 2018 - 2021, USD Million
TABLE 9 Europe PCR Market by Country, 2022 - 2028, USD Million
TABLE 10 Europe Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 11 Europe Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 12 Europe NGS Market by Country, 2018 - 2021, USD Million
TABLE 13 Europe NGS Market by Country, 2022 - 2028, USD Million
TABLE 14 Europe Microbiology Culture Market by Country, 2018 - 2021, USD Million
TABLE 15 Europe Microbiology Culture Market by Country, 2022 - 2028, USD Million
TABLE 16 Europe Mass Spectrometry Market by Country, 2018 - 2021, USD Million
TABLE 17 Europe Mass Spectrometry Market by Country, 2022 - 2028, USD Million
TABLE 18 Europe Rapid & Point of Care Market by Country, 2018 - 2021, USD Million
TABLE 19 Europe Rapid & Point of Care Market by Country, 2022 - 2028, USD Million
TABLE 20 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 21 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 22 Europe Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 23 Europe Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 24 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 25 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 26 Europe Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 27 Europe Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 28 Europe Pharmaceutical, Biotechnology Companies & Others Market by Country, 2018 - 2021, USD Million
TABLE 29 Europe Pharmaceutical, Biotechnology Companies & Others Market by Country, 2022 - 2028, USD Million
TABLE 30 Europe Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 31 Europe Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 32 Europe Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2018 - 2021, USD Million
TABLE 33 Europe Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2022 - 2028, USD Million
TABLE 34 Europe Clostridium Difficile (CD) Market by Country, 2018 - 2021, USD Million
TABLE 35 Europe Clostridium Difficile (CD) Market by Country, 2022 - 2028, USD Million
TABLE 36 Europe Drug Resistant Campylobacter (DRC) Market by Country, 2018 - 2021, USD Million
TABLE 37 Europe Drug Resistant Campylobacter (DRC) Market by Country, 2022 - 2028, USD Million
TABLE 38 Europe Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2018 - 2021, USD Million
TABLE 39 Europe Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2022 - 2028, USD Million
TABLE 40 Europe Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2018 - 2021, USD Million
TABLE 41 Europe Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2022 - 2028, USD Million
TABLE 42 Europe Drug Resistant Salmonella (DRNTS) Market by Country, 2018 - 2021, USD Million
TABLE 43 Europe Drug Resistant Salmonella (DRNTS) Market by Country, 2022 - 2028, USD Million
TABLE 44 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 45 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 46 Europe Antimicrobial Resistance Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 47 Europe Antimicrobial Resistance Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 48 Germany Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 49 Germany Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 50 Germany Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 51 Germany Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 52 Germany Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 53 Germany Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 54 Germany Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 55 Germany Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 56 UK Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 57 UK Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 58 UK Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 59 UK Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 60 UK Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 61 UK Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 62 UK Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 63 UK Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 64 France Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 65 France Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 66 France Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 67 France Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 68 France Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 69 France Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 70 France Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 71 France Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 72 Russia Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 73 Russia Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 74 Russia Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 75 Russia Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 76 Russia Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 77 Russia Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 78 Russia Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 79 Russia Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 80 Spain Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 81 Spain Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 82 Spain Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 83 Spain Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 84 Spain Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 85 Spain Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 86 Spain Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 87 Spain Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 88 Italy Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 89 Italy Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 90 Italy Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 91 Italy Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 92 Italy Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 93 Italy Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 94 Italy Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 95 Italy Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 96 Rest of Europe Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 97 Rest of Europe Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 98 Rest of Europe Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 99 Rest of Europe Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 100 Rest of Europe Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 101 Rest of Europe Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 102 Rest of Europe Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 103 Rest of Europe Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 104 Key Information – Abbott Laboratories
TABLE 105 Key information – Becton, Dickinson and Company
TABLE 106 Key information – BioMérieux S.A.
TABLE 107 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 108 Key Information – Danaher Corporation
TABLE 109 Key information – Hologic, Inc.
TABLE 110 Key Information – Vela Diagnostics Pte. Ltd.
TABLE 111 Key Information – Molsid SAS
TABLE 112 Key Information – Visby Medical, Inc.
TABLE 113 key information – Accelerated Technology Laboratories, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Swot analysis: Abbott laboratories
FIG 5 Recent strategies and developments: BioMérieux S.A.
FIG 6 Recent strategies and developments: F. Hoffmann-La Roche Ltd.